United Therapeutics (UTHR) Tops Q1 EPS by $1.69
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $487.61 --0%
Revenue Growth %: -1.2%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -1.2%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.03, $1.69 better than the analyst estimate of $3.34. Revenue for the quarter came in at $461.9 million versus the consensus estimate of $420.02 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Citi upgrades Old Dominion Freight Line to Buy with $223 target
- Barclays Downgrades Ipsen SA (IPN:FP) (IPSEF) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
